Scimedico LLC is a New Jersey company that offers preventive maintenance services spanning necropsy and pathology facility management. The Scimedico LLC team is focused on developments in the clinical laboratory space inhabited by researchers and physician assistants.
An article featured on the Scimedico LLC site details a Yale Cancer Center study that reveals new pathways for treating triple-negative breast cancer when in its advanced stages. The researchers discovered that inhibiting the CECR2 gene hampers expression among tumors that have progressed throughout the body. CECR2 is implicated in enabling the migration of breast cancer cells to adjacent tissues, such that they are not detectable by the host immune system. CECR2 targeting helps activate T-cells, which work in tandem with the immune system to destroy identified tumors. The findings are described as significant in that this approach can be used in tandem with current immunotherapies, which often lack efficacy as mono-therapies and can benefit from a multi-therapy approach.
0 Comments
Leave a Reply. |
AuthorWest Orange, New Jersey’s Scimedico, LLC - Life Sciences Lab Services. Archives
September 2023
Categories
All
|